TY - JOUR
T1 - Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder
T2 - A latent class analysis
AU - Daniulaityte, Raminta
AU - Nahhas, Ramzi W.
AU - Silverstein, Sydney
AU - Martins, Silvia
AU - Zaragoza, Angela
AU - Moeller, Avery
AU - Carlson, Robert G.
N1 - Funding Information:
This study was supported by the National Institute on Drug Abuse (NIDA) Grants: R01 DA040811 (Daniulaityte, PI) and 1R21DA042757 (Daniulaityte, PI). The funding source had no further role in the study design, in the collection, analysis and interpretation of the data, in the writing of the report, or in the decision to submit the paper for publication.
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Aim: Non-prescribed buprenorphine (NPB) use increased in the US. This study aims to characterize heterogeneity in patterns of NPB and other opioid use among individuals with current opioid use disorder. Methods: The study recruited 356 participants in Dayton (Montgomery County), Ohio, area in 2017–2018 using targeted and Respondent Driven Sampling. Participants met the following criteria: 1) 18 years or older, 2) current moderate/severe opioid use disorder (DSM-5), 3) past 6-month NPB use. Latent class analysis (LCA) was conducted to identify subgroups based on past 6-month (days of NPB and heroin/fentanyl use; use of NPB to get high; use of non-prescribed and prescribed pharmaceutical opioids; participation in formal treatment) and lifetime (years since first NPB and other illicit opioid use) characteristics. Selected auxiliary variables were compared across classes using Asparouhov and Muthén's 3-step approach. Results: 49.7% were female, and 88.8% were non-Hispanic whites. 89% used NPB to self-treat withdrawal. LCA resulted in three classes: “Heavy Heroin/Fentanyl Use” (61%), “More Formal Treatment Use” (29%) and “Intense NPB Use” (10%). After adjusting for multiple testing, the following past 6-month variables differed significantly between classes: injection as a primary route of heroin/fentanyl administration (p < 0.001), cocaine use (p = 0.044), unintentional drug overdose (p = 0.023), and homelessness (p = 0.044), with the “Intense NPB Use” class having the lowest prevalences. Conclusion: Predominance of self-treatment goals and the association between more intense NPB use and lower risks of adverse consequences suggest potential harm minimization benefits of NPB use. More research is needed to understand consequences of NPB use over time.
AB - Aim: Non-prescribed buprenorphine (NPB) use increased in the US. This study aims to characterize heterogeneity in patterns of NPB and other opioid use among individuals with current opioid use disorder. Methods: The study recruited 356 participants in Dayton (Montgomery County), Ohio, area in 2017–2018 using targeted and Respondent Driven Sampling. Participants met the following criteria: 1) 18 years or older, 2) current moderate/severe opioid use disorder (DSM-5), 3) past 6-month NPB use. Latent class analysis (LCA) was conducted to identify subgroups based on past 6-month (days of NPB and heroin/fentanyl use; use of NPB to get high; use of non-prescribed and prescribed pharmaceutical opioids; participation in formal treatment) and lifetime (years since first NPB and other illicit opioid use) characteristics. Selected auxiliary variables were compared across classes using Asparouhov and Muthén's 3-step approach. Results: 49.7% were female, and 88.8% were non-Hispanic whites. 89% used NPB to self-treat withdrawal. LCA resulted in three classes: “Heavy Heroin/Fentanyl Use” (61%), “More Formal Treatment Use” (29%) and “Intense NPB Use” (10%). After adjusting for multiple testing, the following past 6-month variables differed significantly between classes: injection as a primary route of heroin/fentanyl administration (p < 0.001), cocaine use (p = 0.044), unintentional drug overdose (p = 0.023), and homelessness (p = 0.044), with the “Intense NPB Use” class having the lowest prevalences. Conclusion: Predominance of self-treatment goals and the association between more intense NPB use and lower risks of adverse consequences suggest potential harm minimization benefits of NPB use. More research is needed to understand consequences of NPB use over time.
KW - Buprenorphine
KW - Buprenorphine diversion
KW - Heroin
KW - Illicit opioids
KW - Non-pharmaceutical fentanyl
KW - Overdose
KW - Self-treatment
UR - http://www.scopus.com/inward/record.url?scp=85072638495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072638495&partnerID=8YFLogxK
U2 - 10.1016/j.drugalcdep.2019.107574
DO - 10.1016/j.drugalcdep.2019.107574
M3 - Article
C2 - 31568934
AN - SCOPUS:85072638495
SN - 0376-8716
VL - 204
JO - Drug and alcohol dependence
JF - Drug and alcohol dependence
M1 - 107574
ER -